Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2008, Vol. 111, No. 7, pp. 3377-3382.
Prepublished online as a Blood First Edition Paper on December 12, 2007; DOI 10.1182/blood-2007-08-106872.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-08-106872v1
111/7/3377    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cozen, W.
Right arrow Articles by Mack, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cozen, W.
Right arrow Articles by Mack, T. M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 13, 2007
Accepted November 3, 2007

Interleukin-2, interleukin-12 and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma

Wendy Cozen*, Parkash S. Gill, Muhammad T. Salam, Alexandra Nieters, Rizwan Masood, Myles G. Cockburn, W. James Gauderman, Otoniel Martinez-Maza, Bharat N. Nathwani, Malcolm C. Pike, David. J. Van Den Berg, Ann S. Hamilton, Dennis M. Deapen, and Thomas M. Mack

Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States
Department of Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States
Division of Clinical Epidemiology, German Cancer Research Center, Heidelberg, Germany
Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
Departments of Obstetrics & Gynecology and Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
Department of Urology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States

* Corresponding author; email: wcozen{at}usc.edu.

Young adult Hodgkin lymphoma (YAHL) is associated clinically with altered immunity, including a systemic defect in cell-mediated responses. There is strong evidence of a genetic contribution to risk so we hypothesized that heritable alterations in cytokine production associated with Th1 function may contribute to susceptibility. We identified twin pairs in whom at least one member had YAHL and measured interleukin-2 (IL-2), interleukin-12 (IL-12) and interferon-{gamma} (IFN-{gamma}) levels in PHA-stimulated peripheral blood mononuclear cell supernatant in 90 case-twins, 84 of their disease-free twins (unaffected co-twins), and 90 matched controls. Mean difference and mean percent difference in cytokine levels between case-twins and controls, and unaffected co-twins and controls were determined using analysis of co-variance. YAHL case-twins and their unaffected co-twins had IL-12 levels that were 60.6% (p=0.002) and 49% (p=0.04) lower than those of their matched controls, respectively. IL-2 levels were significantly higher in case-twins (p=0.049), but not unaffected co-twins (p=0.57), compared to controls. Differences in IFN-{gamma} levels were not statistically significant in either comparison. An IL-12 polymorphism known to regulate expression was associated with a 2.8-fold (p=0.03) increase in YAHL risk. Thus both case-twins and their unaffected co-twins had a decreased ability to produce IL-12, which may contribute to YAHL susceptibility.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Hodgkin twins: double good, double trouble
Richard F. Ambinder
Blood 2008 111: 3310. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
W. Cozen, A. S. Hamilton, P. Zhao, M. T. Salam, D. M. Deapen, B. N. Nathwani, L. M. Weiss, and T. M. Mack
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma
Blood, November 5, 2009; 114(19): 4014 - 4020.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
V. Pistoia, C. Cocco, and I. Airoldi
Interleukin-12 Receptor {beta}2: From Cytokine Receptor to Gatekeeper Gene in Human B-Cell Malignancies
J. Clin. Oncol., October 1, 2009; 27(28): 4809 - 4816.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B.-Y. Tsai, Y.-L. Lin, and B.-L. Chiang
Application of Interleukin-12 Expressing Dendritic Cells for the Treatment of Animal Model of Leukemia
Experimental Biology and Medicine, August 1, 2009; 234(8): 952 - 960.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020